Literature DB >> 24943807

Hobson's choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases.

Suguru Yamashita1, Kiyoshi Hasegawa, Michiro Takahashi, Junichi Arita, Yoshihiro Sakamoto, Taku Aoki, Yasuhiko Sugawara, Norihiro Kokudo.   

Abstract

Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver. To extend the surgical indications for CLM, a planned two-stage hepatectomy procedure with portal vein embolization (PVE) was developed specifically for patients with multiple and bilobar CLM. The rationale for performing the procedure was a concern about the possible overgrowth of intrafuture remnant liver lesions following PVE, and it was therefore recommended for all multiple bilobar CLM cases, even when one-stage hepatectomy was technically feasible. We recently performed Hobson's choice two-stage hepatectomy in two cases for reasons different from those of the original planned two-stage hepatectomy. In the present report, we describe our Hobson's choice two-stage hepatectomy strategy, which provided favorable short-term outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24943807     DOI: 10.1007/s00595-014-0953-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival.

Authors:  I M Shaw; M Rees; F K S Welsh; S Bygrave; T G John
Journal:  Br J Surg       Date:  2006-04       Impact factor: 6.939

2.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

Authors:  S Galandiuk; H S Wieand; C G Moertel; S S Cha; R J Fitzgibbons; J H Pemberton; B G Wolff
Journal:  Surg Gynecol Obstet       Date:  1992-01

3.  Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy.

Authors:  F Lévi; R Zidani; J L Misset
Journal:  Lancet       Date:  1997-09-06       Impact factor: 79.321

4.  Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases.

Authors:  Yoshihiro Mise; Hiroshi Imamura; Takuya Hashimoto; Yasuji Seyama; Taku Aoki; Kiyoshi Hasegawa; Yoshihumi Beck; Yasuhiko Sugawara; Masatoshi Makuuchi; Jun Nakajima; Norihiro Kokudo
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

5.  During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma.

Authors:  D Elias; T De Baere; A Roche; J Leclere; P Lasser
Journal:  Br J Surg       Date:  1999-06       Impact factor: 6.939

6.  Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization.

Authors:  N Kokudo; K Tada; M Seki; H Ohta; K Azekura; M Ueno; K Ohta; T Yamaguchi; T Matsubara; T Takahashi; T Nakajima; T Muto; T Ikari; A Yanagisawa; Y Kato
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

7.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

8.  Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases.

Authors:  D A Wicherts; R J de Haas; P Andreani; D Sotirov; C Salloum; D Castaing; R Adam; D Azoulay
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

9.  One-stage hepatectomy following portal vein embolization for colorectal liver metastasis.

Authors:  Suguru Yamashita; Kiyoshi Hasegawa; Michiro Takahashi; Yosuke Inoue; Yoshihiro Sakamoto; Taku Aoki; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

Review 10.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases.

Authors: 
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

View more
  1 in total

1.  Pros and Cons of Portal Vein Embolization With Hematopoietic Stem Cells Application in Colorectal Liver Metastases Surgery.

Authors:  Vladislav Treska; Jan Bruha; Vaclav Liska; Jakub Fichtl; Kristyna Prochazkova; Tereza Petrakova; Petr Hosek
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.